Related Articles
Phospho-valproic acid inhibits pancreatic cancer growth in mice: enhanced efficacy by its formulation in poly-(L)-lactic acid-poly(ethylene glycol) nanoparticles Corrigendum in /10.3892/ijo.2018.4584
Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer
Docosahexaenoic acid sensitizes colon cancer cells to sulindac sulfide-induced apoptosis
Synergistic cytotoxic effect of sulindac and pyrrolidine dithiocarbamate against ovarian cancer cells
Sulindac enhances arsenic trioxide-mediated apoptosis by inhibition of NF-κB in HCT116 colon cancer cells